Select your area of strategic concern

• Co-development and co-commercialization partnerships
• Licensing and asset-sharing agreements
• Exclusivity and lifecycle extension strategies
• Contract renegotiation under pricing pressure
• Responding to delisting and formulary risk
• Value-based and outcomes-linked contracts

• Pricing strategy and prce-war dynamics
• Responding to biosimilars and generics
• Competitive response to breakthrough therapies
• Managing powerful payers and PBMs
• Impact of GPOs and centralized procurement
• Portfolio positioning across indications
• Multi-brand and line-extension strategies

• Formulary access and reimbursement negotiations
• Patient access and co-payment strategy shifts
• Channel strategy (hospital, spec. pharmacy, DTC)
• Product differentiation byond price
• Launch sequencing across geographies

• R&D portfolio prioritization
• New product launch and indication expansion
• Strategic response to customer vertical integration
• Entry into emerging markets
• M&A, divestitures, and asset swaps
• Capital allocation under uncertainty

• Global distribution network design
• Supply chain resilience and redundancy decisions
• Managing shortages and allocation strategies
• Make-vs-buy and outsourcing choices
• Market exit or product withdrawal strategy

• Regulatory approval strategy across regions
• Engagement with FDA, EMA, and global regulators
• New pricing and transparency regulations
• Government funding and incentive programs
• Budget pressure and policy change response
• Litigation and legal dispute strategy

• Complete the form below for additional information